Donate
Myeloma Minute

New drugs and therapies presented at ASH 2016.

Watch Drs. Brian G.M. Durie, Joseph Mikhael, and Sagar Lonial as they discuss the latest news and trends in the treatment of Multiple Myeloma at the 58th Annual ASH Meeting in San Diego, California.

ASH 2016
December 5, 2016
San Diego, CA

 

Ajai Chari, MD at ASH convention 2017
Daratumumab in Combination with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) in Patients with Newly Diagnosed Multiple Myeloma (MMY1001)
Read more
Elena Zamagni, MD at ASH 2016
ASH 2016: Prospective Evaluation of 18F-FDG PET/CT As Predictor of Prognosis in Newly Diagnosed Transplant Eligible MM Patients
Read more
Previous Post
IMWG: Current relapse options
Next Post
Are tandem stem cell transplants necessary?

Give Where Most Needed

Learn More

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.